首页|血清MC-CP、CCL26、DcR3水平在COPD并发OSAS诊断中的临床价值

血清MC-CP、CCL26、DcR3水平在COPD并发OSAS诊断中的临床价值

扫码查看
目的 探究血清肥大细胞羧肽酶(MC-CP)、趋化因子 26(CCL26)、诱饵受体 3(DcR3)水平在慢性阻塞性肺疾病(COPD)并发阻塞性睡眠呼吸暂停综合征(OSAS)诊断中的临床价值。方法 选取 2021 年 1 月至 2023 年 1 月河北北方学院附属第一医院收治的COPD患者 90 例,其中单纯COPD患者 48 例即为COPD组,COPD合并OSAS患者 42 例即为COPD-OSAS组。同期选取在河北北方学院附属第一医院体检健康志愿者 48 例为对照组。采用酶联免疫吸附试验(ELISA)检测血清MC-CP、CCL26、DcR3 水平。受试者工作特征(ROC)和曲线下面积(AUC)分析血清MC-CP、CCL26、DcR3 水平在COPD并发OSAS诊断中的临床价值。多因素Logistic回归分析COPD并发OSAS的影响因素。结果 与对照组相比,COPD 组和 COPD-OSAS 组患者吸烟指数、C 反应蛋白(CRP)、白细胞计数(WBC)水平依次显著升高,1 秒钟用力呼气容积与用力肺活量的比(FEV1/FVC)依次显著降低(P<0。05);与对照组相比,COPD组和COPD-OSAS组患者MC-CP、CCL26、DcR3 水平依次显著升高(P<0。05);血清MC-CP、CCL26、DcR3 3 者联合对COPD并发OSAS诊断的AUC比单独诊断的更高(Z=4。066,P<0。001;Z=2。391,P<0。05;Z=2。353,P<0。05)。多因素Logistic回归分析显示,吸烟指数、MC-CP、CCL26、DcR3 水平是COPD并发OSAS的影响因素(P<0。05)。结论 COPD并发OSAS患者血清中MC-CP、CCL26、DcR3 表达水平升高,三者联合可提高对COPD并发OSAS的诊断价值。
Clinical value of serum levels of MC-CP,CCL26 and DcR3 in the diagnosis of COPD complicated with OSAS
Objective To investigate the clinical value of serum mast cell carboxypeptidase(MC-CP),C-C motif chemokine 26(CCL26),and decoy receptor 3(DcR3)in the diagnosis of obstructive sleep apnea syndrome(OSAS)in chronic obstructive pulmonary disease(COPD).Methods Ninety COPD patients who visited the First Affiliated Hospital of Hebei North University from January 2021 to January 2023 were collected.Among them,48 patients with simple COPD were included in the COPD group,and 42 patients with COPD combined with OSAS were included in the COPD-OSAS group.During the same period,48 healthy volunteers who underwent physical examination in that Hospital of Hebei North collected as the control group.Enzyme linked immunosorbent assay(ELISA)was applied to detect serum level of MC-CP,CCL26,and DcR3.Receiver operating characteristic(ROC)curve was applied to analyze the clinical value of serum level of MC-CP,CCL26,and DcR3 in the diag-nosis of COPD complicated with OSAS.Multivariate Logistic regression was applied to analyze the influencing fac-tors of COPD complicated with OSAS.Results Compared with the control group,the smoking index,C-reactive protein(CRP)and white blood cell count(WBC)in the COPD and COPD-OSAS groups increased obviously in sequence,the ratio of forced expiratory volume in first second to forced vital capacity(FEV1/FVC)decreased obviously in sequence(P<0.05);Compared with the control group,the level of MC-CP,CCL26,and DcR3 in patients with COPD and COPD-OSAS increased significantly in sequence(P<0.05);The combination of serum MC-CP,CCL26 and DcR3 had a higher area under the curve(AUC)for the diagnosis of COPD complicated with OSAS compared to the individual diagnosis(Z=4.066,P<0.001;Z=2.391,P<0.05;Z=2.353,P<0.05).Multivariate Logistic regression analysis showed that smoking index,serum level of MC-CP,CCL26 and DcR3 were influencing factors for COPD complicated with OSAS(P<0.05).Conclusions The simultane-ously increased expression of MC-CP,CCL26 and DcR3 in the serum of COPD may support clinical diagnostic of COPD patients with OSAS.

mast cell carboxypeptidaseC-C motif chemokine 26decoy receptor 3chronic obstructive pulmonary diseaseobstructive sleep apnea syndrome

陈丽萍、史永兴、陈艳红、冯平、张长洪、林卫佳、项保利

展开 >

河北北方学院附属第一医院 呼吸与危重症医学科,河北 张家口 075000

河北北方学院附属第一医院 病案管理科,河北 张家口 075000

肥大细胞羧肽酶 趋化因子26 诱饵受体3 慢性阻塞性肺疾病 阻塞性睡眠呼吸暂停综合征

2025

基础医学与临床
北京生理科学会

基础医学与临床

影响因子:0.669
ISSN:1001-6325
年,卷(期):2025.45(1)